Shorted

CU6 vs GLC — ASX Short Interest Comparison

Side-by-side comparison of short positions for Clarity Pharmaceuticals (ASX:CU6) and Glencore (ASX:GLC), based on official ASIC short position reports as of 26 Oct 2026.

GLC is more heavily shorted, with 14.23% of shares reported as short positions against 10.45% for CU6 — a gap of 3.79 percentage points.

CU6

Clarity Pharmaceuticals

Short interest
10.45%
Reported positions
38,970,240
Industry
Pharmaceuticals, Biotechnology & Life Sciences

GLC

More shorted

Glencore

Short interest
14.23%
Reported positions
6,261,996
Industry
Materials

Source: official ASIC short position reports (T+4 delay). Methodology · Disclaimer — not financial advice.